Medicine and Dentistry
Gastric Inhibitory Polypeptide
100%
Glucagon Like Peptide 2
100%
Bone Turnover
57%
Placebo
57%
Drug Therapy
57%
Osteoporosis
57%
Peptide YY
57%
Glucagon Like Peptide 1
57%
Bone Remodeling
57%
Gastrointestinal Hormone
57%
Receptor
54%
Osteolysis
43%
Food Intake
42%
G Protein Coupled Receptor
28%
Gut
28%
Ossification
18%
Procollagen
15%
Amino Terminal Sequence
15%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon Like Peptide 2
100%
Gastric Inhibitory Polypeptide
100%
Pharmacotherapy
57%
Gastrointestinal Hormone
57%
Placebo
57%
Peptide YY
57%
Glucagon-Like Peptide-1
57%
Receptor
51%
G Protein Coupled Receptor
28%
Procollagen
16%
Keyphrases
Bone Metabolism
57%
Potential Drugs
57%
Glucagon-like
57%
Drug Therapy
57%
Osteoporosis Treatment
57%
Gut Hormones
57%
Peptide YY
32%
Glucose-dependent Insulinotropic Polypeptide
24%
G Protein-coupled Receptor
16%
Food Intake
16%
Bone Resorption
16%